Mark Ingram

Internal Medicine clinician in Bronx, New York — also lists obesity medicine in the CMS registry.

Practice Details

Address
234 E 149th St
Bronx, NY 10451
Geocoded location: 40.8176, -73.9238
Taxonomy
Surgery
NPPES Enumeration
Listed with NPPES since 2006
Sole Proprietor
No
Provider Gender (NPPES)
Male
NPPES Record Updated
September 2025

Specialty taxonomies on file (2)

  • Internal Medicine
    Internal Medicine, Gastroenterology
    Primary
  • Bariatric Surgery
    Surgery

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

Mark Ingram is an Internal Medicine clinician in Bronx whose NPPES record also lists an obesity-medicine or bariatric-medicine taxonomy as a secondary specialty. Primary-care and family-medicine clinicians who carry this secondary designation are among those most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices — call ahead to confirm.

Locally, this is 1 of 131 Surgery practices in Bronx carrying this exact taxonomy in our directory.

What to expect at an Internal Medicine visit

Internal-medicine practices manage adult and often complex chronic conditions. A GLP-1-related visit commonly involves:

  • •A review of chronic conditions, medications, and cardiovascular/metabolic risk.
  • •Baseline labs (A1c, metabolic panel, lipids) to guide treatment.
  • •A discussion of GLP-1 options for diabetes and/or weight management.
  • •A plan for follow-up monitoring and dose adjustment.

This is general guidance for internal medicine practices, not a description of Mark Ingram's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 718-579-5900.

GLP-1 access in Bronx, New York

Adult obesity rate
28.9%
#41 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$229/mo
Typical New York telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
New York Medicaid, obesity indication

About 28.9% of New York adults have obesity (BMI 30+), ranking the state #41 of 50 (CDC BRFSS). Our directory currently lists 86 GLP-1-relevant clinics in Bronx. If a cash-pay route makes more sense, compounded semaglutide through New York telehealth averages about $229/mo — well below brand-name Wegovy or Zepbound.

Explore more New York options on the best New York GLP-1 providers page, browse every Bronx listing in the Bronx clinic directory.

Related Practices in Bronx

Other Bronx listings in the same directory tier:

James Goldszer
Family Medicine
Meyer Halberstam
Internal Medicine
Eugene Edynak
Family Medicine

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to New York addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured New York telehealth partners:

Featured Partners · Bronx

Featured GLP-1 providers serving Bronx

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick
    7.6
    Maximus

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. 8.3
    Found

    Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. 7.4
    Breeze Meds

    Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. 6.2
    Wellorithm

    Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2
    Gala

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. 6.9
    TMates

    Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →
See all 182 GLP-1 providers serving Bronx ↓

See more Bronx options on the Bronx clinic directory, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Bronx obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Mark Ingram's specialty taxonomy but not the specific medications it prescribes or its current service menu. Mark Ingram is listed under Internal Medicine, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 718-579-5900 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Mark Ingram's primary specialty on file is Internal Medicine, with obesity medicine listed as a secondary taxonomy. Generalist clinicians who carry that secondary designation are among those who commonly manage GLP-1 prescribing, though the registry does not confirm current services.
Mark Ingram is located at 234 E 149th St, Bronx, NY 10451. The phone number listed in the registry is 718-579-5900. Its full record is public in the CMS National Provider registry under NPI 1710040621.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Mark Ingram is currently accepting new patients. Call the practice at 718-579-5900 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.